Free Trial
NASDAQ:CHEK

Check-Cap (CHEK) Stock Price, News & Analysis

Check-Cap logo
$1.11
-0.03 (-2.63%)
(As of 10/31/2024 ET)

About Check-Cap Stock (NASDAQ:CHEK)

Key Stats

Today's Range
$1.10
$1.13
50-Day Range
$1.14
$1.93
52-Week Range
$1.10
$3.94
Volume
14,450 shs
Average Volume
87,035 shs
Market Capitalization
$6.49 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

Check-Cap Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
9th Percentile Overall Score

CHEK MarketRank™: 

Check-Cap scored higher than 9% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Check-Cap is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Check-Cap is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Check-Cap has a P/B Ratio of 0.27. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Check-Cap's valuation and earnings.
  • Percentage of Shares Shorted

    0.37% of the float of Check-Cap has been sold short.
  • Short Interest Ratio / Days to Cover

    Check-Cap has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Check-Cap has recently increased by 37.82%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Check-Cap does not currently pay a dividend.

  • Dividend Growth

    Check-Cap does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.37% of the float of Check-Cap has been sold short.
  • Short Interest Ratio / Days to Cover

    Check-Cap has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Check-Cap has recently increased by 37.82%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Check-Cap has a news sentiment score of 0.30. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Check-Cap this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    2 people have added Check-Cap to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Check-Cap insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.48% of the stock of Check-Cap is held by insiders.

  • Percentage Held by Institutions

    Only 1.07% of the stock of Check-Cap is held by institutions.

  • Read more about Check-Cap's insider trading history.
Receive CHEK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Check-Cap and its competitors with MarketBeat's FREE daily newsletter.

CHEK Stock News Headlines

Check-Cap (NASDAQ:CHEK) Now Covered by Analysts at StockNews.com
[625,000% Gain] – Are You Ready for the Next Altcoin Boom?
All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.
See More Headlines

CHEK Stock Analysis - Frequently Asked Questions

Check-Cap's stock was trading at $2.08 on January 1st, 2024. Since then, CHEK stock has decreased by 46.6% and is now trading at $1.11.
View the best growth stocks for 2024 here
.

Check-Cap Ltd. (NASDAQ:CHEK) posted its quarterly earnings results on Monday, November, 27th. The medical research company reported ($0.44) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.39.

Check-Cap shares reverse split on the morning of Friday, November 25th 2022. The 1-20 reverse split was announced on Friday, November 25th 2022. The number of shares owned by shareholders was adjusted after the market closes on Friday, November 25th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Check-Cap (CHEK) raised $13 million in an IPO on Thursday, February 19th 2015. The company issued 1,200,000 shares at a price of $10.00-$12.00 per share. Chardan Capital Markets and Maxim Group served as the underwriters for the IPO and Feltl and Company was co-manager.

Shares of CHEK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Check-Cap investors own include NVIDIA (NVDA), PayPal (PYPL), Meta Platforms (META), Alibaba Group (BABA), Advanced Micro Devices (AMD), Palantir Technologies (PLTR) and Tesla (TSLA).

Company Calendar

Last Earnings
11/27/2023
Today
10/31/2024
Next Earnings (Estimated)
11/25/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
X - ray apparatus & tubes
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CHEK
Employees
80
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$4.05 per share

Miscellaneous

Free Float
5,823,000
Market Cap
$6.55 million
Optionable
Not Optionable
Beta
0.36

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

This page (NASDAQ:CHEK) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners